Literature DB >> 17482474

Role of erythropoietin in the brain.

Constance Tom Noguchi1, Pundit Asavaritikrai, Ruifeng Teng, Yi Jia.   

Abstract

Multi-tissue erythropoietin receptor (EPO-R) expression provides for erythropoietin (EPO) activity beyond its known regulation of red blood cell production. This review highlights the role of EPO and EPO-R in brain development and neuroprotection. EPO-R brain expression includes neural progenitor cells (NPC), neurons, glial cells and endothelial cells. EPO is produced in brain in a hypoxia sensitive manner, stimulates NPC proliferation and differentiation, and neuron survival, and contributes to ischemic preconditioning. Mice lacking EPO or EPO-R exhibit increased neural cell apoptosis during development before embryonic death due to severe anemia. EPO administration provides neural protection in animal models of brain ischemia and trauma, reducing the extent of injury and damage. Intrinsic EPO production in brain and EPO stimulation of endothelial cells contribute to neuroprotection and these are of particular importance since only low levels of EPO appear to cross the blood-brain barrier when administered at high dose intravenously. The therapeutic potential of EPO for brain ischemia/trauma and neurodegenerative diseases has shown promise in early clinical trial and awaits further validation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482474      PMCID: PMC2083122          DOI: 10.1016/j.critrevonc.2007.03.001

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  119 in total

1.  Beneficial effect of erythropoietin on experimental allergic encephalomyelitis.

Authors:  Weiping Li; Yasuhiro Maeda; Rui Rong Yuan; Stella Elkabes; Stuart Cook; Peter Dowling
Journal:  Ann Neurol       Date:  2004-12       Impact factor: 10.422

2.  Erythropoietin treatment improves neurological functional recovery in EAE mice.

Authors:  Jing Zhang; Yi Li; Yisheng Cui; Jieli Chen; Mei Lu; Stanton B Elias; Michael Chopp
Journal:  Brain Res       Date:  2005-02-09       Impact factor: 3.252

3.  Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor.

Authors:  Barbara Viviani; Stefano Bartesaghi; Emanuela Corsini; Pia Villa; Pietro Ghezzi; Angela Garau; Corrado L Galli; Marina Marinovich
Journal:  J Neurochem       Date:  2005-04       Impact factor: 5.372

4.  The oviduct produces erythropoietin in an estrogen- and oxygen-dependent manner.

Authors:  S Masuda; T Kobayashi; M Chikuma; M Nagao; R Sasaki
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-06       Impact factor: 4.310

Review 5.  Effects of erythropoietin on brain function.

Authors:  W Jelkmann
Journal:  Curr Pharm Biotechnol       Date:  2005-02       Impact factor: 2.837

6.  Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury.

Authors:  S E Juul; S A Stallings; R D Christensen
Journal:  Pediatr Res       Date:  1999-11       Impact factor: 3.756

7.  The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.

Authors:  Anargyros Xenocostas; Wing K Cheung; Francis Farrell; Cindy Zakszewski; Marian Kelley; Andrzej Lutynski; Michael Crump; Jeffrey H Lipton; Thomas L Kiss; Catherine Y Lau; Hans A Messner
Journal:  Eur J Clin Pharmacol       Date:  2005-03-18       Impact factor: 2.953

Review 8.  Emerging biological roles for erythropoietin in the nervous system.

Authors:  Michael Brines; Anthony Cerami
Journal:  Nat Rev Neurosci       Date:  2005-06       Impact factor: 34.870

9.  Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity.

Authors:  D Banerjee; M Rodriguez; M Nag; J W Adamson
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

10.  Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa.

Authors:  William A Banks; Nelson L Jumbe; Catherine L Farrell; Michael L Niehoff; Anne C Heatherington
Journal:  Eur J Pharmacol       Date:  2004-11-28       Impact factor: 4.432

View more
  80 in total

1.  Improved cerebrovascular function and reduced histological damage with darbepoietin alfa administration after cortical impact injury in rats.

Authors:  Leela Cherian; J Clay Goodman; Claudia Robertson
Journal:  J Pharmacol Exp Ther       Date:  2011-01-26       Impact factor: 4.030

2.  Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke.

Authors:  Damjan Osredkar; Jeffrey W Sall; Philip E Bickler; Donna M Ferriero
Journal:  Neurobiol Dis       Date:  2010-02-01       Impact factor: 5.996

Review 3.  Regulation of erythropoietin production.

Authors:  Wolfgang Jelkmann
Journal:  J Physiol       Date:  2010-11-15       Impact factor: 5.182

4.  Erythropoietin Stimulates Tumor Growth via EphB4.

Authors:  Sunila Pradeep; Jie Huang; Edna M Mora; Alpa M Nick; Min Soon Cho; Sherry Y Wu; Kyunghee Noh; Chad V Pecot; Rajesha Rupaimoole; Martin A Stein; Stephan Brock; Yunfei Wen; Chiyi Xiong; Kshipra Gharpure; Jean M Hansen; Archana S Nagaraja; Rebecca A Previs; Pablo Vivas-Mejia; Hee Dong Han; Wei Hu; Lingegowda S Mangala; Behrouz Zand; Loren J Stagg; John E Ladbury; Bulent Ozpolat; S Neslihan Alpay; Masato Nishimura; Rebecca L Stone; Koji Matsuo; Guillermo N Armaiz-Peña; Heather J Dalton; Christopher Danes; Blake Goodman; Cristian Rodriguez-Aguayo; Carola Kruger; Armin Schneider; Shyon Haghpeykar; Padmavathi Jaladurgam; Mien-Chie Hung; Robert L Coleman; Jinsong Liu; Chun Li; Diana Urbauer; Gabriel Lopez-Berestein; David B Jackson; Anil K Sood
Journal:  Cancer Cell       Date:  2015-10-17       Impact factor: 31.743

5.  Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.

Authors:  Mingjun Shi; Brianna Flores; Peng Li; Nancy Gillings; Kathryn L McMillan; Jianfeng Ye; Lily Jun-Shen Huang; Sachdev S Sidhu; Yong-Ping Zhong; Maria T Grompe; Philip R Streeter; Orson W Moe; Ming Chang Hu
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

6.  Exogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats.

Authors:  R C Li; S Z Guo; M Raccurt; E Moudilou; G Morel; K R Brittian; D Gozal
Journal:  Neuroscience       Date:  2011-08-23       Impact factor: 3.590

7.  Regulation of gene expression in ischemic preconditioning in the brain.

Authors:  Tuo Yang; Qianqian Li; Feng Zhang
Journal:  Cond Med       Date:  2017-12-15

8.  Retinal vascular repair and neovascularization are not dependent on CX3CR1 signaling in a model of ischemic retinopathy.

Authors:  Lian Zhao; Wenxin Ma; Robert N Fariss; Wai T Wong
Journal:  Exp Eye Res       Date:  2009-01-07       Impact factor: 3.467

9.  Intranasal Erythropoietin Protects CA1 Hippocampal Cells, Modulated by Specific Time Pattern Molecular Changes After Ischemic Damage in Rats.

Authors:  R J Macias-Velez; L Fukushima-Díaz de León; C Beas-Zárate; M C Rivera-Cervantes
Journal:  J Mol Neurosci       Date:  2019-05-03       Impact factor: 3.444

Review 10.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.